Skip to content

Antibiotics in oral cancer

Prophylactic antibiotics in operable oral cancer: short course versus prolonged course - a randomized control trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/05/005790
Enrollment
1360
Registered
2015-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with operable oral cancer

Interventions

Intervention1: Short Course Antibiotics: Prophylactic perioperative antibiotics given intravenously for 24 hours Control Intervention1: Prolonged course antibiotics: Prophylactic perioperative antibio

Sponsors

Tata Memorial Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18 years or older 2. ECOG performance status of 0 or 1 3. Biopsy proven squamous cell carcinoma of oral cavity 4. Patients must have normal organ and marrow function: absolute neutrophil count (ANC) >= 1,500/mm3 5. Willing and able to comply with all study requirements, including treatment (Surgery and reconstruction), timing and/or nature of required assessments. 6. Signed, written, informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with known hypersensitivity to Cephalosporins/Penicillins 2. Patients with immunosuppresion 3. Significant renal dysfunction requiring dose reduction of antibiotics 4. Documented preoperative surgical field infection (Patients with fungating wounds may be included, provided there is no active infection at the incision site i.e either frank erythema or pus from wound or as per treating cliniciansâ?? opinion.) 5. Known colonisation with methicillin resistant Staphylococcus aureus or vancomycin resistant Enterococcus 6. Patients with oral cancer undergoing clean surgery (e.g. neck dissection alone) 7. Pregnancy or lactation

Design outcomes

Primary

MeasureTime frame
Presence of Surgical Site infection Surgical site infection will be defined by Johnsonâ??s criteria28 (Grade 4 or more ) (Table 3), or documentation by the investigator as presence of SSI or restart of antibiotic for SSI. It will be documented as Yes/ No. Timepoint: Will be assessed on postoperative day3, 5 and at discharge and upto 30 days or development of SSI whichever is earlier

Secondary

MeasureTime frame
Rate of surgical site infection The rate of surgical site infection will be measured as the no of cases of SSI in each group divided by the total number of subjects in each group Timepoint: After end of 30 days of last patient recruited

Countries

India

Contacts

Public ContactDeepa Nair

Tata Mmeorial Centre

drdeepanair78@gmail.com02224177282

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026